In our subsequent research, we will further investigate whether Nrf2 undergoes nuclear translocation, clarify how GSPE activates the Nrf2/HO-1 signalling pathway, and explore its potential targets to closely integrate it with clinical treatment of DKD. This evidence concerns the gene NFE2L2 and diabetic kidney disease.